Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Unity Biotechnology, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +7 vs. Q3 2023
- Shares held
- 4.32M
- +1.64M (+61.4%) vs. Q3 2023
- Total value
- $8.33M
- +$1.91M (+29.8%) vs. Q3 2023
- New holders
- 8
- 7 more added
- Sold out
- 1
- 10 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 6 | $1.68K |
| Q2 2025 | 35 | $987.3K |
| Q1 2025 | 40 | $2.95M |
| Q4 2024 | 37 | $3.10M |
| Q3 2024 | 38 | $5.09M |
| Q2 2024 | 39 | $4.66M |
| Q1 2024 | 40 | $5.87M |
| Q4 2023 | 42 | $8.33M |
| Q3 2023 | 36 | $6.42M |
| Q2 2023 | 40 | $6.87M |
| Q1 2023 | 46 | $5.13M |
| Q4 2022 | 54 | $12.6M |
| Q3 2022 | 72 | $24.1M |
| Q2 2022 | 66 | $5.31M |
| Q1 2022 | 71 | $14.2M |
| Q4 2021 | 72 | $21.3M |
| Q3 2021 | 84 | $42.1M |
| Q2 2021 | 98 | $84.0M |
| Q1 2021 | 92 | $121.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 8 | $15 | 0.00% | +8 | New |
| Qube Research & Technologies Ltd | 18 | $35 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 37 | $71 | 0.00% | −53−58.9% | Reduced |
| AllSquare Wealth Management LLC | 55 | $106 | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 100 | $193 | 0.00% | 00.0% | Unchanged |
| Carmichael Hill & Associates, Inc. | 100 | $193 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 129 | $248 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 200 | $386 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 257 | $496 | 0.00% | +6+2.4% | Added |
| Cape Investment Advisory, Inc. | 300 | $579 | 0.00% | +300 | New |
| Royal Bank of Canada | 461 | $1.00K | 0.00% | −1,453−75.9% | Reduced |
| Glen Eagle Advisors, LLC | 1,104 | $2.13K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2,000 | $3.86K | 0.00% | +1,800+900.0% | Added |
| Simplex Trading, LLC | 2,313 | $4.00K | 0.00% | +2,313 | New |
| Tower Research Capital LLC (TRC) | 2,428 | $4.69K | 0.00% | +2,428 | New |
| UBS Group AG | 9,300 | $17.9K | 0.00% | +8,940+2,483.3% | Added |
| CIBC Asset Management Inc | 10,634 | $20.5K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 13,206 | $25.5K | 0.00% | −9,910−42.9% | Reduced |
| Millennium Management LLC | 13,438 | $25.9K | 0.00% | +13,438 | New |
| Susquehanna International Group, LLP | 15,958 | $30.8K | 0.00% | −3,223−16.8% | Reduced |
| XTX Topco Ltd | 20,971 | $40.5K | 0.01% | +20,971 | New |
| Laurion Capital Management LP | 21,569 | $41.6K | 0.00% | −48,431−69.2% | Reduced |
| Northern Trust Corp | 21,638 | $41.8K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 23,612 | $46.0K | 0.00% | −750−3.1% | Reduced |
| Dimensional Fund Advisors LP | 25,500 | $49.2K | 0.00% | −14,219−35.8% | Reduced |
| Jane Street Group, LLC | 28,455 | $54.9K | 0.00% | +11,360+66.5% | Added |
| Morgan Stanley | 36,760 | $70.9K | 0.00% | +6,114+20.0% | Added |
| State Street Corp | 37,824 | $73.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 38,171 | $74.0K | 0.00% | −200−0.5% | Reduced |
| Cercano Management LLC | 41,238 | $79.6K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 43,504 | $84.0K | 0.00% | +50.0% | Added |
| Citadel Advisors LLC | 48,676 | $93.9K | 0.00% | +48,676 | New |
| Founders Fund V Management, LLC | 49,172 | $94.9K | 10.03% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 50,000 | $96.5K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 92,700 | $178.9K | 0.01% | −86,380−48.2% | Reduced |
| BlackRock Inc. | 113,081 | $218.2K | 0.00% | −376−0.3% | Reduced |
| Mayo Clinic | 124,081 | $239.5K | 1.48% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 131,782 | $254.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 561,602 | $1.08M | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 688,000 | $1.33M | 0.04% | +688,000 | New |
| ARCH Venture Management, LLC | 1,004,817 | $1.94M | 1.19% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 1,041,331 | $2.01M | 0.01% | +1,002,636+2,591.1% | Added |
| TSFG, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Johnson Midwest Financial, LLC | – | – | – | – | Not filed |